Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
-6.2%/yr
Long-term compound
Percentile
P92
Near historical high
vs 5Y Ago
0.7x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 22.82% |
| Q2 2025 | -20.21% |
| Q1 2025 | -20.79% |
| Q4 2024 | -17.11% |
| Q3 2024 | -24.75% |
| Q2 2024 | -18.73% |
| Q1 2024 | -15.08% |
| Q4 2023 | -4.15% |
| Q3 2023 | -10.10% |
| Q2 2023 | -4.13% |
| Q1 2023 | -7.34% |
| Q4 2022 | -10.53% |
| Q3 2022 | -12.86% |
| Q2 2022 | -30.50% |
| Q1 2022 | -5.06% |
| Q4 2021 | -3.88% |
| Q3 2021 | -5.51% |
| Q2 2021 | 62.33% |
| Q1 2021 | -0.72% |
| Q4 2020 | 1.93% |
| Q3 2020 | 31.47% |
| Q2 2020 | -5.52% |
| Q1 2020 | 50.16% |
| Q4 2019 | -61.15% |
| Q3 2019 | -1.96% |
| Q2 2019 | -1.81% |
| Q1 2019 | 11.27% |
| Q4 2018 | -44.78% |
| Q3 2018 | -1.71% |
| Q2 2018 | 4.64% |
| Q1 2018 | -0.58% |
| Q4 2017 | -0.68% |
| Q3 2017 | -1.68% |
| Q2 2017 | 1.49% |
| Q1 2017 | -1.89% |
| Q4 2016 | -43.47% |
| Q3 2016 | 0.34% |
| Q2 2016 | -2.23% |
| Q1 2016 | 0.42% |
| Q4 2015 | -15.75% |